Global Medical REIT (GMRE) Scheduled to Post Earnings on Wednesday

Global Medical REIT (NYSE:GMRE) is set to release its Q2 2019 earnings data after the market closes on Wednesday, August 7th. Analysts expect Global Medical REIT to post earnings of $0.19 per share for the quarter.

Global Medical REIT (NYSE:GMRE) last issued its earnings results on Wednesday, May 8th. The company reported $0.02 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.20 by ($0.18). The firm had revenue of $15.20 million for the quarter, compared to the consensus estimate of $15.32 million. Global Medical REIT had a net margin of 21.38% and a return on equity of 5.52%. On average, analysts expect Global Medical REIT to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Shares of NYSE GMRE opened at $10.27 on Tuesday. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.76. The firm’s fifty day moving average price is $10.61. The company has a market cap of $342.77 million, a price-to-earnings ratio of 13.17, a PEG ratio of 1.47 and a beta of 0.41. Global Medical REIT has a twelve month low of $8.15 and a twelve month high of $11.51.

The company also recently announced a quarterly dividend, which was paid on Thursday, July 11th. Shareholders of record on Wednesday, June 26th were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 7.79%. The ex-dividend date of this dividend was Tuesday, June 25th. Global Medical REIT’s dividend payout ratio (DPR) is presently 102.56%.

A number of brokerages have weighed in on GMRE. ValuEngine lowered Global Medical REIT from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Zacks Investment Research upgraded Global Medical REIT from a “strong sell” rating to a “hold” rating in a report on Thursday, July 11th. Boenning Scattergood reiterated a “buy” rating and issued a $11.00 price target on shares of Global Medical REIT in a report on Friday, May 10th. TheStreet upgraded Global Medical REIT from a “c+” rating to a “b” rating in a report on Thursday, May 9th. Finally, Stifel Nicolaus initiated coverage on Global Medical REIT in a report on Monday, April 15th. They issued a “buy” rating and a $11.00 price target on the stock. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $10.67.

About Global Medical REIT

Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Further Reading: How to Track your Portfolio in Google Finance

Earnings History for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with's FREE daily email newsletter.